NCT01225939View on ClinicalTrials.gov

A Study Conducted Over 3 Periods to Look at the Drug in the Body

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

AZD8329

tablet

DRUG

AZD8329

Solution

Trial Locations (1)

Unknown

Research Site, London Bridge

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY